Meilleur Technologies

Founded: 2018 • Age: 8 yrs Acquired By Lantheus
Provider of biomarkers and therapeutics development services

About Meilleur Technologies

Meilleur Technologies is a Healthcare company founded in 2018, and was acquired by Lantheus in July 2024. Provider of biomarkers and therapeutics development services. Meilleur Technologies offers products and services including NAV-4694 and Imaging Tools. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides. Its legal entity is Meilleur Technologies Inc.

Company details

Meilleur Technologies provider of biomarkers and therapeutics development services through providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics

Products & Services of Meilleur Technologies

Meilleur Technologies offers a comprehensive portfolio of products and services, including NAV-4694 and Imaging Tools.

NAV-4694
Imaging Agent

Beta-amyloid imaging biomarker for Alzheimer's detection in clinical trials.

Imaging Tools
Technology Platform

Provides informatics and tools for neurological research and diagnostics.

Investors in Meilleur Technologies

Meilleur Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lantheus.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Developer of diagnostic imaging agents and targeted therapeutics
2008lantheus.comBillerica, United States
Premium access

Investor details for Meilleur Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Meilleur Technologies

2 dated milestones of Meilleur Technologies across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Meilleur Technologies is founded.
  2. Exit Acquired by Lantheus.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Meilleur Technologies

Premium access

Complete news archive for Meilleur Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meilleur Technologies

Meilleur Technologies was founded in 2018.

Meilleur Technologies provider of biomarkers and therapeutics development services through providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Meilleur Technologies offers NAV-4694 and Imaging Tools.

Meilleur Technologies has 1 investor. Key investors include Lantheus.

Meilleur Technologies operates through Meilleur Technologies Inc..

Yes. Meilleur Technologies was acquired by Lantheus in July 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available